Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2
Jason A. Somarelli(Duke University), Mariano A. García-Blanco(Duke Medical Center), Shivee Gilja(Duke Medical Center), Herbert Levine(The University of Texas MD Anderson Cancer Center), Andrew J. Armstrong(Duke Medical Center), Samantha Shetler(Duke Medical Center), Suzanne Bartholf DeWitt(Duke Medical Center), Mohit Kumar Jolly(The University of Texas MD Anderson Cancer Center), Xueyang Wang(Duke University), Alexander J. Hish(Duke Medical Center), Kathryn E. Ware(University of Colorado Denver), William C. Eward(North Carolina State University)
Cited by 105
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
|Journal of Clinical Oncology|2016|1.6k
Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
|Molecular Cancer Research|2011|650
Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis
|Nature Genetics|2007|649
Plastic pollution solutions: emerging technologies to prevent and collect marine plastic pollution
|Environment International|2020|440